SIMONATO, Michele
 Distribuzione geografica
Continente #
NA - Nord America 10.966
EU - Europa 4.592
AS - Asia 2.058
SA - Sud America 22
OC - Oceania 3
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.645
Nazione #
US - Stati Uniti d'America 10.948
PL - Polonia 1.893
CN - Cina 1.075
UA - Ucraina 602
IT - Italia 567
SG - Singapore 476
DE - Germania 396
TR - Turchia 357
RU - Federazione Russa 342
GB - Regno Unito 311
FI - Finlandia 168
SE - Svezia 124
ID - Indonesia 66
CZ - Repubblica Ceca 51
FR - Francia 45
VN - Vietnam 31
AT - Austria 27
BE - Belgio 23
CA - Canada 15
LT - Lituania 14
IR - Iran 13
CO - Colombia 12
IN - India 11
BR - Brasile 8
HK - Hong Kong 8
NL - Olanda 7
KR - Corea 6
ES - Italia 4
IE - Irlanda 4
PT - Portogallo 4
AU - Australia 3
CH - Svizzera 3
PK - Pakistan 3
DK - Danimarca 2
EU - Europa 2
JP - Giappone 2
MX - Messico 2
MY - Malesia 2
AR - Argentina 1
AZ - Azerbaigian 1
BG - Bulgaria 1
CL - Cile 1
EG - Egitto 1
GT - Guatemala 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
KW - Kuwait 1
LB - Libano 1
MA - Marocco 1
NO - Norvegia 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 17.645
Città #
Warsaw 1.892
Fairfield 1.546
Woodbridge 1.533
Houston 856
Ashburn 818
Jacksonville 719
Chandler 675
Ann Arbor 607
Seattle 603
Wilmington 539
Cambridge 502
Singapore 381
Santa Clara 357
Beijing 254
Nanjing 231
Izmir 229
Ferrara 195
Princeton 169
San Diego 147
Shanghai 95
New York 92
Boardman 88
Milan 83
Jakarta 65
Los Angeles 63
Nanchang 63
Shenyang 56
Jiaxing 49
Washington 49
Dearborn 42
Brno 41
Changsha 35
Helsinki 34
Bremen 33
Hebei 33
Munich 32
Norwalk 31
Dong Ket 30
London 30
Tianjin 30
Kunming 29
Vienna 27
Redwood City 26
Mountain View 24
Jinan 23
San Mateo 23
Auburn Hills 22
Brussels 22
Ningbo 22
Falls Church 18
Zhengzhou 17
Bologna 16
Des Moines 16
Verona 16
Rome 14
Bogotá 12
Frankfurt am Main 11
Philadelphia 11
Augusta 10
Guangzhou 10
Tappahannock 10
Toronto 10
Hangzhou 9
Orange 9
Phoenix 9
Hong Kong 8
Kilburn 8
Olomouc 8
Redmond 8
Taizhou 8
Changchun 7
Düsseldorf 7
Lanzhou 7
Lappeenranta 7
Leawood 7
Addison 6
Ardabil 6
Haikou 5
Monmouth Junction 5
Pisa 5
Arezzo 4
Chicago 4
Dublin 4
Hefei 4
Hounslow 4
Islington 4
Candia Lomellina 3
Chiswick 3
Como 3
Indiana 3
Leipzig 3
Orciano di Pesaro 3
Paris 3
Perugia 3
Pieve Emanuele 3
Serpa 3
Turin 3
Vicenza 3
Wandsworth 3
Amsterdam 2
Totale 13.910
Nome #
Microdialysis of Excitatory Amino Acids During EEG Recordings in Freely Moving Rats 448
Is autopsy tissue a valid control for epilepsy surgery tissue in microRNA studies? 314
MicroRNA profiles in hippocampal granule cells and plasma of rats with pilocarpine-induced epilepsy - Comparison with human epileptic samples 293
Systems genetics identifies Sestrin 3 as a regulator of a proconvulsant gene network in human epileptic hippocampus 289
WONOEP appraisal: New genetic approaches to study epilepsy 282
Meta-analysis of microRNAs dysregulated in the hippocampal dentate gyrus of animal models of epilepsy 275
Progress in gene therapy for neurological disorders 273
Harmonization in preclinical epilepsy research: A joint AES/ILAE translational initiative 272
Deletion of the Virion Host Shut-off Gene Enhances Neuronal-Selective Transgene Expression from an HSV Vector Lacking Functional IE Genes 271
The challenge and promise of anti-epileptic therapy development in animal models 270
Standardization procedure for plasma biomarker analysis in rat models of epileptogenesis: Focus on circulating microRNAs 269
Bystander effect on brain tissue of mesoangioblasts producing neurotrophins 264
Identification and characterization of outcome measures reported in animal models of epilepsy: Protocol for a systematic review of the literature-€“A TASK2 report of the AES/ILAE Translational Task Force of the ILAE 251
Effects of defective herpes simplex vectors expressing neurotrophic factors on the proliferation and differentiation of nervous cells in vivo 145
Engineered HSV vector achieves safe long-term transgene expression in the central nervous system 145
Adenosine A1 receptors in the rat brain in the kindling model of epilepsy 142
A pathogenetic hypothesis of temporal lobe epilepsy 141
FGF-2 Overexpression Increases Excitability and Seizure Susceptibility but Decreases Seizure-Induced Cell Loss 141
Hippocampal FGF-2 and BDNF overexpression attenuates epileptogenesis-associated neuroinflammation and reduces spontaneous recurrent seizures. 141
Kainate seizures increase nociceptin/orphanin FQ release in the rat hippocampus and thalamus: a microdialysis study 137
Angels and demons: neurotrophic factors and epilepsy 132
A pathogenetic hypothesis of Unverricht-Lundborg disease onset and progression 131
Loss of cortical GABA terminals in Unverricht–Lundborg disease 130
Decreased levels of neuropeptide Y5 receptor binding sites in two experimental models of epilepsy 130
Personalized needles for microinjections in the rodent brain 129
Adenosine receptor antagonists alter the stability of human epileptic GABAA receptors 128
Advances in the development of biomarkers for epilepsy 128
Characterization of K+-evoked [3H]d-aspartate outflow in the rat hippocampus in vitro 127
Functional antagonism between nociceptin/orphanin FQ (N/OFQ) and corticotropin releasing factor (CRF) in the rat brain: evidence for involvement of the bed nucleus of the stria terminalis 126
GABAA-Current Run-down of Temporal Lobe Epilepsy is Associated with Repetitive Activation of GABAA "Phasic" Receptors 124
Characterization of glutamate and [3H]D-aspartate outflow from various in vitro preparations of the rat hippocampus. 124
Effects of [Nphe(1), Arg(14), Lys(15)] N/OFQ-NH2 (UFP-101), a potent NOP receptor antagonist, on molecular, cellular and behavioural alterations associated with chronic mild stress 124
The neurochemistry of morphine addiction in the neocortex. 123
null 123
Nociceptin/Orphanin FQ Receptor Agonists Attenuate L-DOPA-Induced Dyskinesias 123
5-Hydroxytryptamine-mediated effects of nicotine on endogenous GABA efflux from guinea-pig cortical slices. 123
Synthesis and anticonvulsant activity of a class of 2-amino 3-hydroxypropanamide and 2-aminoacetamide derivatives 122
Brain-derived neurotrophic factor mRNA and protein are targeted to discrete dendritic laminas by events that trigger epileptogenesis 122
Changes in cortical ACh and GABA outflow during morphine withdrawal involve alpha-1 and alpha-2 receptors 120
Alterations in seizure susceptibility and in seizure-induced plasticity after pharmacologic and genetic manipulation of the Fibroblast Growth Factor-2 system 120
Dendritic targeting of mRNAs for plasticity genes in experimental models of temporal lobe epilepsy 119
Silencing status epilepticus-induced BDNF expression with herpes simplex virus type-1 based amplicon vectors 119
Antinociceptive activity of the N-Methyl-D- Aspartate Receptor Antagonist N-(2-indanyl)-glycinamide hydrochloride CHF3381 in Experimental Models of Inflammatory and Neuropathic Pain 118
Effect of arachidonic acid on [3H]d-aspartate outflow in the rat hippocampus 117
Dose- and time-dependent hippocampal cholinergic lesions induced by ethylcholine mustard aziridinium ion: effects of nerve growth factor, GM1 ganglioside and vitamin E 115
Localized overexpression of FGF-2 and BDNF in hippocampus reduces mossy fiber sprouting and spontaneous seizures up to 4 weeks after pilocarpine-induced status epilepticus 114
Involvement of the neuropeptide nociceptin/orphanin FQ in kainate seizures 114
Induction of B-1 bradykinin receptors in the kindled hippocampus increases extracellular glutamate levels: A microdialysis study 114
Blockade of nociceptin/orphanin FQ transmission attenuates symptoms and neurodegeneration associated with Parkinson's disease 114
eIF4B phosphorylation at Ser504 links synaptic activity with protein translation in physiology and pathology 114
Changes in NPY-mediated modulation of hippocampal [H-3]D-aspartate outflow in the kindling model of epilepsy 113
Early changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures in the rat. 113
Involvement of the neuropeptide Orphanin FQ/Nociceptin in kainate and kindling seizures and epileptogenesis. 113
Fisiologia e fisiopatologia di BDNF: verso lo sviluppo di nuove strategie terapeutiche per alcune delle principali malattie neuro-psichiatriche 113
Pro-nociceptin/orphanin FQ and NOP receptor mRNA levels in the forebrain of food deprived rats 113
Induction of B1 bradykinin receptors in the kindled brain. 112
Mechanisms of action of CHF3381 in the forebrain 111
null 111
Biotin-deficiency facilitates kindling hyperexcitability in rats. 110
Differential expression of immediate early genes in the hippocampus in the kindling model of epilepsy 109
Fibroblast Growth Factor-2 (FGF-2). 109
The biocompatibility of materials used in printed circuit board technologies with respect to primary neuronal and K562 cells 109
Are the neurotrophic factors a suitable therapeutic target for the prevention of epileptogenesis? 109
Common data elements and data management: Remedy to cure underpowered preclinical studies 109
Delayed epileptogenesis in nociceptin/orphanin FQ-deficient mice 106
Acetylcholine content in rat brain is elevated by status epilepticus induced by lithium and pilocarpine 106
WONOEP appraisal: Development of epilepsy biomarkers-What we can learn from our patients? 106
Replication-defective herpes simplex virus vectors for neurotrophic factor gene transfer in vitro and in vivo 106
Opportunities for improving animal welfare in rodent models of epilepsy and seizures 106
Finding a better drug for epilepsy: Preclinical screening strategies and experimental trial design 105
Targeting kinin receptors for the treatment of neurological diseases 104
Evaluation of cell damage in organotypic hippocampal slice culture from adult mouse: a potential model system to study neuroprotection 104
Identification of new epilepsy treatments for: issues in preclinical methodology 102
Gene Therapy Tools for Brain Diseases 102
Changes in hippocampal and cortical B1 bradykinin receptor biological activity in two experimental models of epilepsy 102
Autoradiographic analysis of rat brain kinin B-1 and B-2 receptors: Normal distribution and alterations induced by epilepsy 101
Differences in the anatomic distribution of immediate-early gene expression in amygdala and angular bundle kindling development 100
Finding a better drug for epilepsy: Antiepileptogenesis targets 100
BODIPY (R)-conjugated neuropeptide Y ligands: new fluorescent tools to tag Y1, Y2, Y4 and Y5 receptor subtypes 100
Seizure-Suppressant and Neuroprotective Effects of Encapsulated BDNF-Producing Cells in a Rat Model of Temporal Lobe Epilepsy 99
Opioid peptides and seizures. 98
Circadian differences in the individual sensitivity to opiate overdose 98
What is the biological significance of BDNF mRNA targeting in the dendrites? Clues from epilepsy and cortical development. 98
null 97
Cell Therapy for Epilepsy 96
Long-term, targeted delivery of GDNF from encapsulated cells is neuroprotective and reduces seizures in the pilocarpine model of epilepsy 96
Time- and region-specific variations in somatostatin release following amygdala kindling in the rat 95
null 95
On the role of somatostatin in seizure control: Clues from the hippocampus 95
Limbic seizures increase pronociceptin mRNA levels in the thalamic reticular nucleus. 94
null 94
null 94
Unverricht-Lundborg disease 94
A Matter of Genes: The Hurdles of Gene Therapy for Epilepsy 94
null 94
null 93
null 93
Kindled seizure-induced c-fos and prodynorphin mRNA expressions are unrelated in the rat brain. 93
Region-specific changes in prodynorphin mRNA and ir-dynorphin A levels after kindled seizures. 92
null 92
Totale 13.528
Categoria #
all - tutte 76.342
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.657
Totale 78.999


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.309 0 0 0 0 0 438 382 391 327 431 218 122
2020/20212.528 203 254 132 247 140 242 138 283 111 353 281 144
2021/20221.730 58 233 132 51 37 57 99 114 74 116 185 574
2022/20231.607 192 68 104 160 247 221 66 180 205 12 99 53
2023/20241.348 96 109 63 24 94 278 111 142 77 81 64 209
2024/20251.213 133 115 337 174 450 4 0 0 0 0 0 0
Totale 17.912